Cargando…
Age-Related Seroprevalence of Antibodies Against AAV-LK03 in a UK Population Cohort
Recombinant adeno-associated virus (rAAV) vectors are a promising platform for in vivo gene therapy. The presence of neutralizing antibodies (Nab) against AAV capsids decreases cell transduction efficiency and is a common exclusion criterion for participation in clinical trials. Novel engineered cap...
Autores principales: | Perocheau, Dany P., Cunningham, Sharon C., Lee, Juhee, Antinao Diaz, Juan, Waddington, Simon N., Gilmour, Kimberly, Eaglestone, Simon, Lisowski, Leszek, Thrasher, Adrian J., Alexander, Ian E., Gissen, Paul, Baruteau, Julien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343184/ https://www.ncbi.nlm.nih.gov/pubmed/30027761 http://dx.doi.org/10.1089/hum.2018.098 |
Ejemplares similares
-
Safety and efficacy of an engineered hepatotropic AAV gene therapy for ornithine transcarbamylase deficiency in cynomolgus monkeys
por: Baruteau, Julien, et al.
Publicado: (2021) -
Characterization of the humanized FRG mouse model and development of an AAV-LK03 variant with improved liver lobular biodistribution
por: Cabanes-Creus, Marti, et al.
Publicado: (2023) -
Clinical applications for exosomes: Are we there yet?
por: Perocheau, Dany, et al.
Publicado: (2021) -
Cervical Gene Delivery of the Antimicrobial Peptide, Human β-Defensin (HBD)-3, in a Mouse Model of Ascending Infection-Related Preterm Birth
por: Suff, Natalie, et al.
Publicado: (2020) -
Gene therapy for monogenic liver diseases: clinical successes, current challenges and future prospects
por: Baruteau, Julien, et al.
Publicado: (2017)